Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-Current Deferred Tax Liability: 2018-2020

Historic Non-Current Deferred Tax Liability for Akebia Therapeutics (AKBA) over the last 1 years, with Mar 2020 value amounting to $35.1 million.

  • Akebia Therapeutics' Non-Current Deferred Tax Liability rose 806.04% to $35.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $35.1 million, marking a year-over-year increase of 806.04%. This contributed to the annual value of $109.4 million for FY2019, which is 8.42% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Non-Current Deferred Tax Liability of $35.1 million as of Q1 2020, which was down 67.90% from $109.4 million recorded in Q4 2019.
  • Akebia Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $119.4 million during Q4 2018, with a 5-year trough of $1.8 million in Q3 2019.
  • For the 3-year period, Akebia Therapeutics' Non-Current Deferred Tax Liability averaged around $45.4 million, with its median value being $19.5 million (2019).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first dropped by 8.42% in 2019, then soared by 806.04% in 2020.
  • Akebia Therapeutics' Non-Current Deferred Tax Liability (Quarterly) stood at $119.4 million in 2018, then dropped by 8.42% to $109.4 million in 2019, then surged by 806.04% to $35.1 million in 2020.
  • Its Non-Current Deferred Tax Liability was $35.1 million in Q1 2020, compared to $109.4 million in Q4 2019 and $1.8 million in Q3 2019.